Two Sigma Securities’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Two Sigma Securities’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,559	Closed	-$242K	–	3507
2022 Q3	$242K	Buy	+3,559	New	+$196K	0.01%	1775
2021 Q1	–	Sell	-7,601	Closed	-$329K	–	1936
2020 Q4	$329K	Buy	+7,601	New	+$375K	0.01%	971
2020 Q1	–	Sell	-5,718	Closed	-$455K	–	2539
2019 Q4	$455K	Buy	+5,718	New	+$339K	﹤0.01%	1499
2017 Q2	–	Sell	-9,546	Closed	-$352K	–	1253
2017 Q1	$352K	Buy	+9,546	New	+$240K	0.07%	298

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Securities's GBT Position: Q4 2022 in Review

Two Sigma Securities sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,559 shares — an estimated $242K sold.

Two Sigma Securities first reported a position in GBT in Q1 2017 and held it in 4 quarters. The position peaked at $455K in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Two Sigma Securities reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Two Sigma Securities sold 3,559 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $242K.
Two Sigma Securities first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
Two Sigma Securities's Global Blood Therapeutics, Inc. position peaked at $455K in Q4 2019.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.